This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: The Innovations of Makoto Ubutaka
Introduction
Makoto Ubutaka is a notable inventor based in Imizu-gun, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotics. His work has led to advancements that could potentially improve healthcare outcomes.
Latest Patents
Ubutaka holds a patent for Antibiotics RK-1061 and the process for preparing the same. This antibiotic features a novel chemical structure and a method of production that involves culturing a ray fungus belonging to a specific genus. The structural formula of RK-1061 is represented by a general formula where A represents R or RCH(OR)CH, R represents a 3-methylglutaric acid residue, and R can be a sulfate group or a hydrogen atom. The process is notable for its high productivity in producing RK-1061.
Career Highlights
Throughout his career, Ubutaka has been associated with Daiichi Pharmaceutical Co., Ltd., where he has contributed to various research initiatives. His innovative approach to antibiotic development has garnered attention in the pharmaceutical industry.
Collaborations
Ubutaka has worked alongside esteemed colleagues such as Ken-ichi Kimura and Yoshikazu Ikeda. Their collaborative efforts have furthered research and development in the field of antibiotics.
Conclusion
Makoto Ubutaka's contributions to antibiotic research exemplify the importance of innovation in healthcare. His patent for Antibiotics RK-1061 represents a significant advancement in pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile